C67.2
Malignant neoplasm of lateral wall of bladder
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the lateral wall of the bladder, classified under ICD-10 code C67.2, refers to a type of bladder cancer that originates on the outer side (lateral wall) of the bladder. The bladder is a hollow organ in the pelvis that stores urine, and cancers in this area can affect urinary function and overall health. Recognizing the characteristics and potential implications of this condition is vital for understanding its diagnosis, treatment options, and prognosis.
Causes & Symptoms
Clinical Causes: Smoking cigarettes or using tobacco products Chronic bladder inflammation or infections Exposure to certain chemicals and industrial toxins History of previous bladder cancer or radiation therapy Genetic predisposition or family history of bladder cancer Age, with higher incidence in older adults Male gender, as bladder cancer is more common in men
Key Symptoms: Blood in the urine (hematuria), which may be visible or detected through tests Pain or a burning sensation during urination Frequent urination or feeling the need to urinate urgently Pelvic discomfort or pressure Back pain, especially in the lower back Unexplained weight loss and fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: The diagnosis of bladder cancer involving the lateral wall typically involves a combination of tests. These may include a urinalysis to detect blood or abnormal cells, imaging studies such as ultrasound, CT scans, or MRI to visualize the bladder and surrounding tissues, and cystoscopy—an endoscopic procedure that allows direct inspection of the bladder interior. During cystoscopy, tissue samples (biopsies) may be taken for histopathological examination to confirm malignancy and assess the tumor's grade and extent.
Treatment Protocols: Treatment options are tailored to the tumor's stage, grade, and overall patient health. Common approaches include: - Transurethral resection of bladder tumor (TURBT): Minimally invasive removal of the tumor via cystoscopy. - Intravesical therapy: Administration of medications directly into the bladder, such as immunotherapy or chemotherapy, to target residual cancer cells. - Radical cystectomy: Surgical removal of the entire bladder and surrounding tissues, often indicated for invasive cancers. - Systemic chemotherapy: Used in advanced cases to destroy cancer cells throughout the body. - Radiation therapy: May be considered in certain situations, either alone or combined with other treatments. Multidisciplinary management is essential for optimal outcomes, involving urologists, oncologists, and radiologists, among other specialists.
Clinical Advice & FAQs
Billing Guidance
Is C67.2 a billable ICD-10 code?
Yes, C67.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C67.2?
Clinical documentation must specify the nature of Malignant neoplasm of lateral wall of bladder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference